LACK OF EFFECT OF CERTAIN HISTAMINE-H2-RECEPTOR BLOCKERS ON THE GLUCURONIDATION OF 7-HYDROXY-4-METHYLCOUMARIN BY HUMAN LIVER-MICROSOMES

被引:1
作者
IRSHAID, Y [1 ]
ABUKHALAF, M [1 ]
机构
[1] JORDAN UNIV SCI & TECHNOL,FAC MED,DEPT SURG,IRBID,JORDAN
来源
PHARMACOLOGY & TOXICOLOGY | 1992年 / 71卷 / 04期
关键词
D O I
10.1111/j.1600-0773.1992.tb00986.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Contrary to the general belief that cimetidine and ranitidine spare glucuronidation of drugs, some authors have indicated that both cimetidine and ranitidine could inhibit the glucuronidation of paracetamol (acetaminophen) by cultured rat hepatocytes. Thus, we tested the effect of three histamine H-2-receptor blockers (cimetidine, ranitidine and famotidine) on the glucuronidation of 7-hydroxy-4-methylcoumarin (7-OH-4-MC) by human liver microsomes. None of the drugs studied produced significant inhibition of the glucuronidation of 7-OH-4-MC when used at concentrations up to 1.5 mM. Thus, even the new H-2-receptor blocker, famotidine, spares glucuronidation. These findings further support the previous reports which suggest that glucuronide conjugation in humans is spared by H-2-receptor blockers.
引用
收藏
页码:294 / 296
页数:3
相关论文
共 16 条
[1]  
ABERNETHY DR, 1983, J PHARMACOL EXP THER, V224, P508
[2]   THE EFFECT OF CIMETIDINE AND RANITIDINE ON PARACETAMOL GLUCURONIDATION AND SULFATION IN CULTURED RAT HEPATOCYTES [J].
EMERY, S ;
OLDHAM, HG ;
NORMAN, SJ ;
CHENERY, RJ .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (09) :1415-1421
[3]   GLUCURONIDATION OF 7-HYDROXY-4-METHYLCOUMARIN BY HUMAN LIVER-MICROSOMES - INHIBITION BY CERTAIN DRUGS [J].
IRSHAID, YM ;
GHARAYBEH, KI ;
AMMARI, FF ;
RAWASHDEH, NM .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1990, 15 (04) :295-301
[4]  
IRSHAID YM, 1987, MOL PHARMACOL, V31, P27
[5]  
IRSHAID YM, 1991, DRUG METAB DISPOS, V19, P173
[6]   RANITIDINE AT VERY LARGE DOSES DOES NOT INHIBIT THEOPHYLLINE ELIMINATION [J].
KELLY, HW ;
POWELL, JR ;
DONOHUE, JF .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (05) :577-581
[7]   THE EFFECT OF LIVER-CIRRHOSIS ON THE PHARMACOKINETICS OF PHENPROCOUMON [J].
KITTERINGHAM, NR ;
BUSTGENS, L ;
BRUNDERT, E ;
MINESHITA, S ;
OHNHAUS, EE .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (01) :65-70
[8]   NEWER H-2-RECEPTOR ANTAGONISTS - CLINICAL PHARMACOKINETICS AND DRUG-INTERACTION POTENTIAL [J].
KRISHNA, DR ;
KLOTZ, U .
CLINICAL PHARMACOKINETICS, 1988, 15 (04) :205-215
[9]   DETERMINANTS OF ACETAMINOPHEN METABOLISM - EFFECT OF INDUCERS AND INHIBITORS OF DRUG-METABOLISM ON ACETAMINOPHENS METABOLIC PATHWAYS [J].
MINERS, JO ;
ATTWOOD, J ;
BIRKETT, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (04) :480-486
[10]   SELECTIVE-INHIBITION OF ACETAMINOPHEN OXIDATION AND TOXICITY BY CIMETIDINE AND OTHER HISTAMINE H2-RECEPTOR ANTAGONISTS INVIVO AND INVITRO IN THE RAT AND IN MAN [J].
MITCHELL, MC ;
SCHENKER, S ;
SPEEG, KV .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (02) :383-391